Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex.
about
Structure of the VP16 transactivator target in the MediatorSolution NMR structure of MED25(391–543) comprising the activator-interacting domain (ACID) of human mediator subunit 25Interaction studies of the human and Arabidopsis thaliana Med25-ACID proteins with the herpes simplex virus VP16- and plant-specific Dreb2a transcription factorsCharacterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25Role of the IE62 consensus binding site in transactivation by the varicella-zoster virus IE62 proteinIdentification of functional domains of the IR2 protein of equine herpesvirus 1 required for inhibition of viral gene expression and replication.Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments.Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication.Neuronal fate specification by the Dbx1 transcription factor is linked to the evolutionary acquisition of a novel functional domain.Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.Molecular studies of the Oka varicella vaccine.Mechanisms of Mediator complex action in transcriptional activation.The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group membersIntervention of Phytohormone Pathways by Pathogen Effectors.Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25
P2860
Q27667187-95AAFCD9-FEA0-40CA-906B-14A7F0C49C34Q27670982-522E498F-2628-4AFA-BAE2-D740B598A72FQ28539189-B1CD9F67-1221-4A22-90EA-89AA65FA86E2Q28610740-3EF0D2D0-1549-42E9-82F7-A4ADD99F7039Q33769312-74F981FD-6252-4129-A632-0EF5C67B23C3Q36073810-06F9AE5A-8847-48C4-97CF-882FF5360B18Q36434189-29E3F4BB-1D4B-4AB8-A260-AFA620B51AD4Q36691874-94663D78-CBC8-4527-AC4A-2B829E14F584Q36784535-FB36EAB0-1767-4EA6-A33B-FFC24D39C201Q37171438-7C602158-D740-4DBF-88C6-1D50B8D0735CQ37515240-861CE81D-6E6E-4AFC-BDC4-FA9D3FCFE868Q37932527-0DACB776-DEFB-4B7F-9EB6-FE83C51AC604Q38077643-205A19E8-FA11-49AE-993B-E047B54E7434Q39175285-364AFFFD-34A3-4F89-96C8-F29F5CFD4C5EQ44072212-C44EA7EF-2C1F-4029-8A69-CE479FB90529Q58582749-D5A5FB30-993D-48CC-AC71-7650190FE5ED
P2860
Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of the varicella-zost ...... th the human mediator complex.
@en
Analysis of the varicella-zost ...... th the human mediator complex.
@nl
type
label
Analysis of the varicella-zost ...... th the human mediator complex.
@en
Analysis of the varicella-zost ...... th the human mediator complex.
@nl
prefLabel
Analysis of the varicella-zost ...... th the human mediator complex.
@en
Analysis of the varicella-zost ...... th the human mediator complex.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of the varicella-zost ...... th the human mediator complex.
@en
P2093
Alexander Eletsky
Shinobu Yamamoto
Thomas Szyperski
William T Ruyechan
P2860
P304
P356
10.1128/JVI.00054-09
P407
P577
2009-04-08T00:00:00Z